FDAnews
www.fdanews.com/articles/142254-fda-extends-taliglucerase-alfa-pdufa-date-to-may-1-2012

FDA Extends Taliglucerase Alfa PDUFA Date to May 1, 2012

December 6, 2011
Protalix BioTherapeutics announced it received notification that the FDA has extended the Prescription Drug User Fee Act (PDUFA) goal date of the New Drug Application for taliglucerase alfa to May 1, 2012, a three-month extension from the previous date.
The Sacramento Bee